Voss Capital, LP - Sep 24, 2025 Form 3 Insider Report for Rein Therapeutics, Inc. (RNTX)

Role
10%+ Owner
Signature
Voss Capital, LP; By: /s/ Travis W. Cocke, Managing Member
Stock symbol
RNTX
Transactions as of
Sep 24, 2025
Transactions value $
$0
Form type
3
Date filed
10/3/2025, 03:09 PM
Previous filing
Apr 2, 2025
SEC
View on sec.gov

Reporting Owners (5)

Name Relationship Address Signature Signature date CIK
Voss Capital, LP 10%+ Owner 3773 RICHMOND AVENUE, SUITE 850, HOUSTON Voss Capital, LP; By: /s/ Travis W. Cocke, Managing Member 2025-10-03 0001730145
Voss Value Master Fund, LP 10%+ Owner 3773 RICHMOND AVENUE, SUITE 850, HOUSTON Voss Value Master Fund, LP; By: Voss Advisors GP, LLC; By: /s/ Travis W. Cocke, Managing Member 2025-10-03 0001969435
Voss Value-Oriented Special Situations Fund, LP 10%+ Owner 3773 RICHMOND AVENUE, SUITE 850, HOUSTON Voss Value-Oriented Special Situations Fund, LP; By: Voss Advisors GP, LLC; By: /s/ Travis W. Cocke, Managing Member 2025-10-03 0001863498
Voss Advisors GP, LLC 10%+ Owner 3773 RICHMOND AVENUE, SUITE 850, HOUSTON Voss Advisors GP, LLC; By: /s/ Travis W. Cocke, Managing Member 2025-10-03 0001798309
Cocke Travis W. 10%+ Owner 3773 RICHMOND AVENUE, SUITE 850, HOUSTON /s/ Travis W. Cocke 2025-10-03 0001798383

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNTX Common Stock, $0.001 par value 699K Sep 24, 2025 By: Voss Value Master Fund, LP F1, F2
holding RNTX Common Stock, $0.001 par value 317K Sep 24, 2025 By: Voss Value-Oriented Special Situations Fund, LP F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 is filed jointly by Voss Value Master Fund, LP ("Voss Value Master Fund"), Voss Value-Oriented Special Situations Fund, LP ("Voss Value-Oriented Special Situations Fund"), Voss Advisors GP, LLC ("Voss GP"), Voss Capital, LP ("Voss Capital") and Travis W. Cocke (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2 Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund.
F3 Securities owned directly by Voss Value-Oriented Special Situations Fund. Voss GP, as the general partner of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Voss Capital, as the investment manager of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund.